UK - Avon pension fund could become lead plaintiff in a US class action lawsuit against GlaxoSmithKline.
The debacle flared up after a class action suit was filed in the United States District Court for the Southern District of New York against GlaxoSmithKline (GSK) for investors who purchased GSK sec...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders